Ramosetron

Ramosetron
Clinical data
AHFS/Drugs.com International Drug Names
Routes of
administration
By mouth (ODT), IV
ATC code None
Pharmacokinetic data
Biological half-life 5.8 hours
Identifiers
CAS Number 132907-72-3 YesY
PubChem (CID) 108000
IUPHAR/BPS 2301
[3H]ramosetron: 2305
ChemSpider 97112 N
UNII 7ZRO0SC54Y N
KEGG D02016 N
ChEMBL CHEMBL1643895 N
ECHA InfoCard 100.217.075
Chemical and physical data
Formula C17H17N3O
Molar mass 279.33 g/mol
3D model (Jmol) Interactive image
 NYesY (what is this?)  (verify)

Ramosetron (INN) is a serotonin 5-HT3 receptor antagonist for the treatment of nausea and vomiting.[1] Ramosetron is also indicated for a treatment of "diarrhea-predominant irritable bowel syndrome in males".[2] In India it is marketed under the brand name of IBset.

It is only licensed for use in Japan and selected Southeast Asian countries. In Japan it is sold under the trade name Iribo.[3] Elsewhere it is commonly sold under the trade name Nasea and in India as Nozia (150 μg/mL injection & 100 μg oral tablet).[4]

References

This article is issued from Wikipedia - version of the 10/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.